ArticleDrug safety2026

Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database.

Giuseppe Roberto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.